Article
Peroxisomal biogenesis disorder biomarkers.
Clinical laboratory - 1 Jan 2011
Ghoneim Wafaa, El-Bassyouni Hala T, Abdel Maksoud Soheir A
Abstract excerpt
BACKGROUND: The pathological mechanisms underlying peroxisomal biogenesis disorders (PBD) are not fully understood and the available therapies are not sufficient. This stresses the importance of identifying biochemical markers that reflect the extent of peroxisomal dysfunction in plasma of PBD patients. METHODS: Very long chain fatty acids VLCFAs, Phytanic acid, inflammatory markers: tumor necrosis-alpha,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
